We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
6151
Verrica Pharmaceuticals
VRCA
$91.7M
$35K ﹤0.01%
+217
New +$37.1K
WBS icon
6152
PUT
Webster Financial
WBS
$12.8B
$35K ﹤0.01%
+600
New +$39K
RRD
6153
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$35K ﹤0.01%
6,500
-2,300
-26% -$12.4K
NTGN
6154
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$35K ﹤0.01%
+4,109
New +$45.5K
AQST icon
6155
Aquestive Therapeutics
AQST
$555M
$34K ﹤0.01%
+1,956
New +$32.2K
BC icon
6156
CALL
Brunswick
BC
$5.21B
$34K ﹤0.01%
+500
New +$33.1K
BVN icon
6157
CALL
Compañía de Minas Buenaventura
BVN
$8.78B
$34K ﹤0.01%
2,500
-1,800
-42% -$23.4K
KNDI
6158
CALL
Kandi Technologies Group
KNDI
$63M
$34K ﹤0.01%
7,000
-19,100
-73% -$81.2K
MAN icon
6159
CALL
ManpowerGroup
MAN
$2.62B
$34K ﹤0.01%
400
+300
+300% +$26.7K
UWM icon
6160
CALL
ProShares Ultra Russell2000
UWM
$243M
$34K ﹤0.01%
+800
New +$33.9K
ZUMZ icon
6161
CALL
Zumiez
ZUMZ
$332M
$34K ﹤0.01%
1,300
+100
+8% +$2.62K
BERY
6162
PUT
DELISTED
Berry Global Group, Inc.
BERY
$34K ﹤0.01%
+762
New +$33.5K
LUMO
6163
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$34K ﹤0.01%
1,572
-1,943
-55% -$59.1K
CIM
6164
PUT
Chimera Investment
CIM
$975M
$33K ﹤0.01%
600
-267
-31% -$15K
DTE icon
6165
CALL
DTE Energy
DTE
$28.7B
$33K ﹤0.01%
353
-235
-40% -$21.9K
EUO icon
6166
PUT
ProShares UltraShort Euro
EUO
$33.2M
$33K ﹤0.01%
1,400
+1,000
+250% +$23.1K
FLS icon
6167
PUT
Flowserve
FLS
$10.1B
$33K ﹤0.01%
600
-3,800
-86% -$184K
GIGM icon
6168
GigaMedia
GIGM
$15.8M
$33K ﹤0.01%
11,094
KIM icon
6169
CALL
Kimco Realty
KIM
$16.1B
$33K ﹤0.01%
2,000
+1,900
+1,900% +$31.9K
LOVE
6170
LoveSac
LOVE
$255M
$33K ﹤0.01%
+1,323
New +$27.9K
MLP icon
6171
Maui Land & Pineapple Co
MLP
$323M
$33K ﹤0.01%
2,558
+2,061
+415% +$26.3K
RES icon
6172
CALL
RPC Inc
RES
$1.36B
$33K ﹤0.01%
2,100
-7,400
-78% -$109K
UNFI icon
6173
CALL
United Natural Foods
UNFI
$2.8B
$33K ﹤0.01%
1,100
+200
+22% +$7.24K
TRVN
6174
DELISTED
Trevena, Inc.
TRVN
$33K ﹤0.01%
25
-151
-86% -$152K
CHRA
6175
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$33K ﹤0.01%
+412
New +$33K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.